1. Imfinzi (durvalumab)
    Imfinzi (durvalumab)
    by AstraZeneca Pharmaceuticals LP
    for Urothelial Carcinoma, Lung Cancer
  2. Keytruda (pembrolizumab)
    Keytruda (pembrolizumab)
    by Merck Sharp
    for Urothelial Carcinoma, Gastric Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Skin Cancer
  3. Kisqali (ribociclib)
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
  4. Lonsurf (trifluridine/tipiracil)
    Lonsurf (trifluridine/tipiracil)
    by Les Laboratoires Servier
    for Colorectal Cancer
  5. Lynparza (olaparib)
    Lynparza (olaparib)
    by AstraZeneca AB
    for Breast Cancer, Gynaecological Cancer
  6. Ninlaro (ixazomib)
    Ninlaro (ixazomib)
    by Takeda Pharma A/S
    for Multiple Myeloma
  7. Odomzo (sonidegib)
    Odomzo (sonidegib)
    by Sun Pharmaceutical Industries Europe B.V.
    for Skin Cancer
  8. Onivyde (irinotecan hydrochloride trihydrate)
    Onivyde (irinotecan hydrochloride trihydrate)
    by Baxalta Innovations GmbH
    for Pancreatic Cancer
  9. Opdivo (nivolumab)
    Opdivo (nivolumab)
    by Bristol-Myers Squibb Pharma EEIG
    for Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer
View as Grid List

Items 19-27 of 35

per page
Set Descending Direction